Loading...
XTAETGTR
Market cap15mUSD
Dec 24, Last price  
417.10ILS
1D
-0.43%
1Q
12.55%
Jan 2017
-43.08%
Name

Together Pharma Ltd

Chart & Performance

D1W1MN
XTAE:TGTR chart
P/E
—
P/S
63.32
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
16.07%
Rev. gr., 5y
%
Revenues
91m
+191.42%
37,3371,189,3867,586,09612,114,113000011,223,00012,026,00031,228,00091,006,000
Net income
-4m
L-87.13%
-12,970,873-4,483,606-5,470,405-3,838,052-1,733,760-34,000-149,863,000-15,276,0007,152,000-13,776,000-33,524,000-4,316,000
CFO
15m
P
-4,872,478-3,859,438-2,657,276-4,169,254-3,417,4330-5,379,000-6,833,000-9,703,000-18,644,000-13,733,00014,831,000
Dividend
Mar 29, 20111.5089 ILS/sh
Earnings
Mar 17, 2025

Profile

Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.
URL
https://www.together-pharma.com/
IPO date
May 01, 1993
Employees
70
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
91,006
191.42%
31,228
159.67%
12,026
7.15%
Cost of revenue
68,912
48,727
23,745
Unusual Expense (Income)
NOPBT
22,094
(17,499)
(11,719)
NOPBT Margin
24.28%
Operating Taxes
4,073
847
(12,223)
Tax Rate
18.43%
NOPAT
18,021
(18,346)
504
Net income
(4,316)
-87.13%
(33,524)
143.35%
(13,776)
-292.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
11,528
22,554
BB yield
-57.04%
-31.00%
Debt
Debt current
18,407
21,678
45,904
Long-term debt
48,650
49,423
48,546
Deferred revenue
875
1,875
Other long-term liabilities
54,868
30,554
16,938
Net debt
63,465
65,707
89,355
Cash flow
Cash from operating activities
14,831
(13,733)
(18,644)
CAPEX
(866)
(333)
(1,530)
Cash from investing activities
(1,616)
33,045
(28,850)
Cash from financing activities
(14,920)
(19,143)
48,840
FCF
9,820
13,348
(37,916)
Balance
Cash
3,592
5,296
5,095
Long term investments
98
Excess cash
3,833
4,494
Stockholders' equity
(2,551)
190,578
25,707
Invested Capital
109,671
89,293
124,780
ROIC
18.11%
0.47%
ROCE
20.63%
EV
Common stock shares outstanding
8,785
8,149
6,850
Price
3.88
56.45%
2.48
-76.65%
10.62
-56.31%
Market cap
34,088
68.67%
20,210
-72.22%
72,750
-48.12%
EV
102,795
276,921
167,184
EBITDA
45,948
(11,496)
(6,240)
EV/EBITDA
2.24
Interest
17,036
14,870
Interest/NOPBT